Brought to you by 
Astex evaluates Aventis Pharmaceuticals' compounds
20 Sep 2002
Executive Summary
Astex Technology (structure-based drug discovery) will use its high-throughput x-ray crystallography technology to optimize compounds provided by Aventis Pharmaceuticals (US subsidiary of Aventis SA).
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com